100 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Exploring Analyst Estimates for Shake Shack (SHAK) Q4 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2224662/exploring-analyst-estimates-for-shake-shack-shak-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224662 Feb 12, 2024 - Beyond analysts' top -and-bottom-line estimates for Shake Shack (SHAK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Countdown to Yelp (YELP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS https://www.zacks.com/stock/news/2224677/countdown-to-yelp-yelp-q4-earnings-a-look-at-estimates-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224677 Feb 12, 2024 - Get a deeper insight into the potential performance of Yelp (YELP) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Exploring Analyst Estimates for Hercules Capital (HTGC) Q4 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2224680/exploring-analyst-estimates-for-hercules-capital-htgc-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224680 Feb 12, 2024 - Beyond analysts' top -and-bottom-line estimates for Hercules Capital (HTGC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Exploring Analyst Estimates for Alkermes (ALKS) Q4 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2224682/exploring-analyst-estimates-for-alkermes-alks-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224682 Feb 12, 2024 - Besides Wall Street's top -and-bottom-line estimates for Alkermes (ALKS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Exploring Analyst Estimates for CNH (CNHI) Q4 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2224016/exploring-analyst-estimates-for-cnh-cnhi-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224016 Feb 09, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CNH (CNHI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Ameriprise Financial: EPS Growth Potential But Low Dividend Yield https://seekingalpha.com/article/4668439-ameriprise-financial-eps-growth-potential-but-low-dividend-yield?source=feed_all_articles Feb 07, 2024 - Ameriprise Financial's yield is under 2% now as the share price skyrockets above its moving average. Find out why AMP stock is a Hold.
CVS Health (CVS) Q4 Earnings Top Estimates, 2024 EPS View Down https://www.zacks.com/stock/news/2222702/cvs-health-cvs-q4-earnings-top-estimates-2024-eps-view-down?cid=CS-ZC-FT-analyst_blog|earnings_article-2222702 Feb 07, 2024 - Robust sales growth across all three operating segments contributes to CVS Health's (CVS) Q4 revenues.
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS https://www.zacks.com/stock/news/2221179/inspiremd-s-nspr-ce-mark-recertification-to-boost-cguard-eps?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221179 Feb 05, 2024 - InspireMD's (NSPR) CE Mark Recertification under MDR is likely to help the company boost the CGuard EPS for carotid artery revascularization care along with advancing with new products.
Exploring Analyst Estimates for Tapestry (TPR) Q2 Earnings, Beyond Revenue and EPS https://www.zacks.com/stock/news/2220897/exploring-analyst-estimates-for-tapestry-tpr-q2-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220897 Feb 05, 2024 - Evaluate the expected performance of Tapestry (TPR) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Air Products Sees Q2 Adj. EPS Below Market, Cuts FY24 Outlook; Stock Dips In Pre-market https://www.rttnews.com/story.aspx?Id=3421794 Feb 05, 2024 - Air Products And Chemicals Inc. (APD), while reporting higher first-quarter earnings, but below market estimates, on Monday issued second-quarter outlook, and trimmed fiscal 2024 forecast, both below the Street view.

Pages: 12345678910

<<<Page 6>